found that PGE‐2 mediated cell migration and osteoclastogenesis via its prostaglandin E receptor 2 (EP2) and prostaglandin E receptor 4 (EP4) receptors; therefore, drugs aimed at EP4 showed better selectivity in treating osteoarthritis. This evidence concerns the gene PTGER4 and osteoarthritis.